KR890000108A - 종양 치료용 약제학적 조성물 - Google Patents

종양 치료용 약제학적 조성물 Download PDF

Info

Publication number
KR890000108A
KR890000108A KR1019880007101A KR880007101A KR890000108A KR 890000108 A KR890000108 A KR 890000108A KR 1019880007101 A KR1019880007101 A KR 1019880007101A KR 880007101 A KR880007101 A KR 880007101A KR 890000108 A KR890000108 A KR 890000108A
Authority
KR
South Korea
Prior art keywords
interferon
tumor
pharmaceutically acceptable
acceptable salt
dipyridimol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880007101A
Other languages
English (en)
Korean (ko)
Inventor
노부오 스즈끼
요시아끼 다까꾸보
Original Assignee
디이터 라우디엔, 루돌프 호프만
베링거 인겔하임 인터내셔날 지엠비에이치
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디이터 라우디엔, 루돌프 호프만, 베링거 인겔하임 인터내셔날 지엠비에이치 filed Critical 디이터 라우디엔, 루돌프 호프만
Publication of KR890000108A publication Critical patent/KR890000108A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019880007101A 1987-06-16 1988-06-14 종양 치료용 약제학적 조성물 Ceased KR890000108A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87108708A EP0295317A1 (en) 1987-06-16 1987-06-16 Pharmaceutical composition for the treatment of tumors
EP87108708.6 1987-06-16

Publications (1)

Publication Number Publication Date
KR890000108A true KR890000108A (ko) 1989-03-11

Family

ID=8197069

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880007101A Ceased KR890000108A (ko) 1987-06-16 1988-06-14 종양 치료용 약제학적 조성물

Country Status (11)

Country Link
US (1) US4997645A (cg-RX-API-DMAC10.html)
EP (2) EP0295317A1 (cg-RX-API-DMAC10.html)
JP (1) JPS63316722A (cg-RX-API-DMAC10.html)
KR (1) KR890000108A (cg-RX-API-DMAC10.html)
AT (1) ATE59780T1 (cg-RX-API-DMAC10.html)
AU (1) AU622404B2 (cg-RX-API-DMAC10.html)
DE (1) DE3861494D1 (cg-RX-API-DMAC10.html)
DK (1) DK328088A (cg-RX-API-DMAC10.html)
HU (1) HU200942B (cg-RX-API-DMAC10.html)
PH (1) PH27069A (cg-RX-API-DMAC10.html)
ZA (1) ZA884262B (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215744A (en) * 1987-06-16 1993-06-01 Boehringer Ingelheim Gmbh Methods for the treatment of tumors
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
SE513429C2 (sv) * 1992-06-03 2000-09-11 Syntello Inc Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer
US6003516A (en) * 1992-06-03 1999-12-21 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
US5480640A (en) * 1995-05-02 1996-01-02 Schering Corporation Alpha interferon for treating prostate cancer
US6155266A (en) 1995-05-08 2000-12-05 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
US20020099003A1 (en) 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
WO2020065036A1 (en) * 2018-09-27 2020-04-02 Iteos Therapeutics S.A. Use of an inhibitor of an ent family transporter in the treatment of cancer and combination thereof with an adenosine receptor antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
BG36086A1 (en) * 1982-01-19 1984-09-14 Glbov Method for inducing interferon

Also Published As

Publication number Publication date
HUT47033A (en) 1989-01-30
EP0295317A1 (en) 1988-12-21
EP0295559A3 (en) 1989-03-08
PH27069A (en) 1993-02-01
DE3861494D1 (de) 1991-02-14
AU1768188A (en) 1988-12-22
EP0295559A2 (en) 1988-12-21
JPH0529365B2 (cg-RX-API-DMAC10.html) 1993-04-30
AU622404B2 (en) 1992-04-09
JPS63316722A (ja) 1988-12-26
ATE59780T1 (de) 1991-01-15
DK328088D0 (da) 1988-06-15
DK328088A (da) 1988-12-17
EP0295559B1 (en) 1991-01-09
HU200942B (en) 1990-09-28
ZA884262B (en) 1990-02-28
US4997645A (en) 1991-03-05

Similar Documents

Publication Publication Date Title
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
HUT43985A (en) Process for preparing vinyl phenol derivatives
BR9815439A (pt) Analgesia contìnua obtida com buprenorphine
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE69120430D1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
ATE81984T1 (de) Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten.
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
DE69330150D1 (de) Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
ATE79749T1 (de) Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
KR900017599A (ko) 종양 치료용 약학 조성물
SE9101341D0 (sv) New medicinal use
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
KR900700156A (ko) 개선된 방사선 치료법
KR900002779A (ko) 종양치료용 약학 조성물
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
Wallace Phantom bite: Classification and treatment: Marbach JJ, Varoscak JR, Blank RT, et al. J Prosth Dent 49: 556, 1983

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880614

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930608

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19880614

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19961210

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19970319

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19961210

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I